$250 | Single User
$500 | Site License
$750 | Global License

Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

Published by Global Data: 16 Oct 2018 | 225175 | In Stock

Introduction

Summary

Abbott Laboratories (Abbott) develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; nutritional supplements for infants, children and adults; and products for veterinary care. It has research and development, manufacturing and administrative facilities across the world. The company markets its products in North America, Latin America, the Caribbean, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 7

    List of Figures 9

    Abbott Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 10

    Abbott Laboratories, Medical Equipment Deals By Type, 2012 to YTD 2018 11

    Abbott Laboratories, Medical Equipment, Deals By Region, 2012 to YTD 2018 12

    Abbott Laboratories, Medical Equipment, Deals By Market, 2012 to YTD 2018 13

    Abbott Laboratories, Medical Equipment, Deals Summary, 2012 to YTD 2018 14

    Abbott Laboratories, Medical Equipment, Deal Details 20

    Asset Purchase 20

    Abbott Labs Plans to Acquire Medical Optics and Other Products 20

    Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US.5 Million 21

    Venture Financing 23

    Bigfoot Biomedical Raises USD55 Million in Final Tranche of Series B financing 23

    Kalila Medical Raises Funds Through Venture Financing 25

    Tendyne Raises US Million In Series C Financing 26

    Tendyne Raises US Million In Venture Financing 27

    Spinal Modulation Raises US Million In Venture Financing 28

    Tendyne Raises Additional US.6 Million In Venture Financing 29

    Nanostim Raises US.5 Million In Series C Financing 30

    Topera Raises US Million In Series C Financing 31

    Spinal Modulation Raises US Million In Venture Financing 32

    OptiMedica Raises US Million In Venture Financing 33

    Nanostim Raises US Million In Venture Financing 35

    Topera Raises US Million In Venture Financing 36

    Tendyne Raises US Million In Venture Financing 37

    Nanostim Raises US Million In Venture Financing 38

    Topera Raises US.8 Million In Venture Financing 39

    IDev Technologies Raises US{MAINCONTENT}.83 Million In Venture Financing 40

    Private Equity 41

    Pharos Capital Group Acquires Majority Stake in TechLab 41

    Exponent Private Equity Acquires BBI Diagnostics from Alere for USD162 Million 42

    Partnerships 43

    Abbott Lab Enters into Licensing Agreement with SurModics 43

    Abbott Labs Enters into Licensing Agreement with Beijing Strong Biotechnologies 44

    Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical 45

    Insulet Extends Licensing Agreement with Abbott Diabetes Care 46

    BioPorto Diagnostics Enters Into Licensing Agreement With Abbott Labs 47

    Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics 48

    Robert Bosch Healthcare Systems Enters Into Licensing Agreement With Abbott Diabetes Care 49

    Abbott Enters Into Licensing Agreement With Stanford University For Prostate Cancer Biomarkers 50

    Insulet Amends Licensing Agreement With Abbott Diabetes 51

    Roxwood Medical Enters into Distribution Agreement with Abbott Vascular 52

    Abbott Labs and Bigfoot Biomedical Enter into Agreement 53

    Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 54

    Celgene and Agios Pharma Enter into Agreement with Abbott Labs 55

    Diasend Partners with Abbott Labs 56

    MATTER Enters into Agreement with Abbott 57

    Abbott Enters into Agreement with GE Healthcare 58

    Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 59

    Advanced Biological Enters into Agreement with Abbott for HIV Genotyping Data Analysis Software 60

    Abbott Labs Enters into Co-Development Agreement with US Department of Defense 61

    Abbott Molecular Enters into Co-Development Agreement with Biocartis 62

    Idera Pharma Enters Into Co-Development Agreement With Abbott Molecular For In Vitro Companion Diagnostic Test 63

    Abbott Enters Into Distribution Agreement With R-Pharm For Diabetes Care Products 64

    St. Jude Medical Enters Into Distribution Agreement With Spinal Modulation For Axium Neurostimulator System 65

    Epizyme Enters Into Co-Development Agreement With Abbott Labs 66

    BioGenex Labs Enters Into Co-Marketing Agreement With Abbott Molecular 67

    Cellavision Enters Into Distribution Agreement With Abbott 68

    Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 69

    BioView Enters Into Agreement With Abbott To Develop Automated Cancer Screening System 70

    Abaxis Enters Into Distribution Agreement With Abbott Point of Care For Piccolo Blood Chemistry System 71

    Alere Enters Into Co-Development Agreement With AT&T 72

    Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 73

    Abbott Vascular Enters Into Co-Marketing Agreement With St. Jude Medical 74

    Abbott Enters Into Co-Development Agreement With Genetics Lab For Molecular Assay Development 75

    Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis 76

    Novartis Enters into Licensing Agreement with Abbott Vascular for Everolimus 77

    Equity Offering 78

    Abbott Labs Plans to Raise USD3 Billion in Public Offering of Shares 78

    Debt Offering 79

    Abbott Labs Raises USD1.33 Billion in Public Offering of 1.5% Bonds Due 2026 79

    Abbott Labs Raises USD1.33 Billion in Public Offering of 0.875% Bonds Due 2023 80

    Abbott Labs Raises USD1.33 Billion in Public Offering of Bonds Due 2020 81

    Abbott Labs Raises USD3 Billion in Public Offering of 3.75% Notes due 2026 82

    Abbott Labs Raises USD1.5 Billion in Public Offering of 3.4% Notes Due 2023 84

    Abbott Labs Raises USD1.65 Billion in Public Offering of 4.75% Notes due 2036 86

    Abbott Labs Raises USD2.85 Billion in Public Offering of 2.9% Notes due 2021 88

    Abbott Labs Raises USD2.85 Billion in Public Offering of 2.35% Notes due 2019 90

    Abbott Labs Raises USD3.25 Billion in Public Offering of 4.9% Notes due 2046 92

    Alere Raises USD425 Million in Private Placement of 6.37% Notes Due 2023 94

    Abbott Labs Raises USD750 Million in Public Offering of 2.55% Notes Due 2022 95

    Abbott Labs Raises USD1 Billion in Public Offering of 2.55% Notes Due 2025 96

    Abbott Labs Raises USD2.5 Billion in Public Offering of 2% Notes Due 2020 97

    Alere Completes Private Placement Of Notes Due 2020 For US5 Million 98

    St. Jude Medical Completes Public Offering Of Notes Due 2043 For US0 Million 99

    St. Jude Medical Completes Public Offering Of Notes Due 2023 For US0 Million 101

    Alere Completes Private Placement Of Notes Due 2018 For US0 Million 103

    Abbott Completes Private Placement Of Notes Due 2018 For US Billion 104

    Abbott Completes Private Placement Of Notes Due 2022 For US.1 Billion 105

    Abbott Completes Private Placement Of Notes Due 2042 For US.6 Billion 106

    Abbott Completes Private Placement Of Notes Due 2015 For US.5 Billion 107

    Abbott Completes Private Placement Of Notes Due 2017 For US Billion 108

    Abbott Completes Private Placement Of Notes Due 2015 For US0 Million 109

    Asset Transactions 110

    Quidel Acquires Triage and BNP Business from Alere 110

    Terumo Acquires Portion of Vascular Closure Portfolio and Other Assets from St. Jude Medical and Abbott Labs for USD1.12 Billion 112

    QIAGEN Acquires Circulating Tumor Cell Technology from AdnaGen 114

    Coppersmith Capital Management Reportedly Wants Alere To Explore Sale Of Its Drug Testing And Toxicology Businesses For Up To US Billion 115

    Vascular Solutions Acquires Venture Catheter From St. Jude Medical For US Million 116

    Acquisition 117

    Siemens Healthineers Acquires Epocal from Alere 117

    Abbott Labs Acquires Alere 118

    Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 120

    Abbott Labs Acquires St. Jude Medical for up to USD23.6 Billion 121

    Abbott Labs Acquires Kalila Medical 123

    St. Jude Medical Acquires Thoratec for USD3.3 Billion 124

    Abbott Labs Acquires Remaining Stake in Tendyne for USD250 Million 126

    Abbott Labs Enters into Option Agreement to Acquire Cephea Valve Technologies 127

    Abbott Labs Acquires Omnilab 128

    Alere Acquires US Diagnostics USD60 Million 129

    St. Jude Medical Acquires Spinal Modulation 130

    Abbott Labs Acquires Topera 131

    Abbott Labs Receives Right to Acquire Advanced Cardiac Therapeutics 132

    Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion 133

    Jude Medical Completes Acquisition of NeuroTherm for USD200 Million 134

    St. Jude Medical Completes Acquisition of Remaining 81% Stake in CardioMEMS for USD450 Million 135

    St. Jude Medical Completes Acquisition Of Nanostim For US3.5 Million 137

    Abbott Laboratories Completes Acquisition Of IDev Technologies 139

    Abbott Labs Completes Acquisition Of OptiMedica For Up To USD410 Million 141

    St. Jude Medical Acquires Endosense, Developer Of Cardiovascular Devices 143

    Alere Completes Acquisition Of Epocal For Up To US1 Million 145

    Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 147

    Alere Acquires eScreen for USD296 Million 149

    Arriva Medical Acquires AmMed Direct For US Million 151

    STARLIMS Technologies Acquires Distribution Partners 152

    Arriva Medical Acquires Direct Diabetic Source 153

    Abbott Laboratories - Key Competitors 154

    Abbott Laboratories - Key Employees 155

    Abbott Laboratories - Locations And Subsidiaries 157

    Head Office 157

    Other Locations & Subsidiaries 157

    Recent Developments 175

    Financial Announcements 175

    Jul 18, 2018: Abbott reports second-Quarter 2018 Results 175

    Apr 18, 2018: Abbott Reports First-Quarter 2018 Results 178

    Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results 181

    Oct 18, 2017: Abbott Reports Third-Quarter 2017 Results 184

    Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 187

    Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 189

    Corporate Communications 191

    Aug 01, 2018: Global Healthcare Organizations join Abbott to launch the UNIVANTS of Healthcare Excellence Award 191

    Sep 22, 2017: Abbott and the Abbott Fund Provide Million in Additional Relief to Help Families Affected by Hurricane Maria and the Earthquake in Central Mexico 192

    Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With Million to Help Families Affected by Hurricane Irma 193

    Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 194

    Aug 29, 2017: Abbott and the Abbott Fund Donate Million to Support Hurricane Harvey Relief Efforts 195

    Government and Public Interest 196

    Sep 06, 2018: Eighth Annual MedtechVision Conference to Focus on “The Impact of AI on Medicine” 196

    Jul 20, 2018: Rapid diagnostics deliver shared value 197

    Apr 17, 2018: Battery Performance Alert and Cybersecurity Firmware Updates for Certain Abbott (formerly St. Jude Medical) Implantable Cardiac Devices: FDA Safety Communication 199

    Product News 202

    Apr 17, 2018: Abbott Releases Planned Updates for Implantable Cardiac Devices 202

    Apr 11, 2018: Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease 203

    Oct 30, 2017: Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease With Xience Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery 204

    Aug 29, 2017: Abbott Issues New Updates for Implanted Cardiac Devices 205

    Jul 25, 2017: Abbott Initiates Clinical Trial Of Three-Month Dual Antiplatelet Therapy Following Implantation With Xience Coronary Stent 207

    Other Significant Developments 208

    Jul 28, 2018: FIND announces new wave of activities to address the challenges threatening hepatitis C elimination through potential diagnostic technologies 208

    Jun 19, 2018: ClearStar Expands Medical Testing with Abbott Laboratories Integration 209

    Aug 15, 2017: North West London Pathology and Abbott Partner for Diagnostics Products and Services, Including Alinity, in Three NHS Trusts 210

    Appendix 211

    Methodology 211

    About GlobalData 211

    Contact Us 211

    Disclaimer 211

List Of Tables
in Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

List of Tables

Abbott Laboratories, Medical Equipment, Key Facts, 2017 2

Abbott Laboratories, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Abbott Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 10

Abbott Laboratories, Medical Equipment Deals By Type, 2012 to YTD 2018 11

Abbott Laboratories, Medical Equipment, Deals By Region, 2012 to YTD 2018 12

Abbott Laboratories, Deals By Market, 2012 to YTD 2018 13

Abbott Laboratories, Medical Equipment, Deals Summary, 2012 to YTD 2018 14

Abbott Labs Plans to Acquire Medical Optics and Other Products 20

Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US.5 Million 21

Bigfoot Biomedical Raises USD55 Million in Final Tranche of Series B financing 23

Kalila Medical Raises Funds Through Venture Financing 25

Tendyne Raises US Million In Series C Financing 26

Tendyne Raises US Million In Venture Financing 27

Spinal Modulation Raises US Million In Venture Financing 28

Tendyne Raises Additional US.6 Million In Venture Financing 29

Nanostim Raises US.5 Million In Series C Financing 30

Topera Raises US Million In Series C Financing 31

Spinal Modulation Raises US Million In Venture Financing 32

OptiMedica Raises US Million In Venture Financing 33

Nanostim Raises US Million In Venture Financing 35

Topera Raises US Million In Venture Financing 36

Tendyne Raises US Million In Venture Financing 37

Nanostim Raises US Million In Venture Financing 38

Topera Raises US.8 Million In Venture Financing 39

IDev Technologies Raises US{MAINCONTENT}.83 Million In Venture Financing 40

Pharos Capital Group Acquires Majority Stake in TechLab 41

Exponent Private Equity Acquires BBI Diagnostics from Alere for USD162 Million 42

Abbott Lab Enters into Licensing Agreement with SurModics 43

Abbott Labs Enters into Licensing Agreement with Beijing Strong Biotechnologies 44

Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical 45

Insulet Extends Licensing Agreement with Abbott Diabetes Care 46

BioPorto Diagnostics Enters Into Licensing Agreement With Abbott Labs 47

Axis-Shield Diagnostic Enters into Licensing Agreement with Siemens Healthcare Diagnostics 48

Robert Bosch Healthcare Systems Enters Into Licensing Agreement With Abbott Diabetes Care 49

Abbott Enters Into Licensing Agreement With Stanford University For Prostate Cancer Biomarkers 50

Insulet Amends Licensing Agreement With Abbott Diabetes 51

Roxwood Medical Enters into Distribution Agreement with Abbott Vascular 52

Abbott Labs and Bigfoot Biomedical Enter into Agreement 53

Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 54

Celgene and Agios Pharma Enter into Agreement with Abbott Labs 55

Diasend Partners with Abbott Labs 56

MATTER Enters into Agreement with Abbott 57

Abbott Enters into Agreement with GE Healthcare 58

Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 59

Advanced Biological Enters into Agreement with Abbott for HIV Genotyping Data Analysis Software 60

Abbott Labs Enters into Co-Development Agreement with US Department of Defense 61

Abbott Molecular Enters into Co-Development Agreement with Biocartis 62

Idera Pharma Enters Into Co-Development Agreement With Abbott Molecular For In Vitro Companion Diagnostic Test 63

Abbott Enters Into Distribution Agreement With R-Pharm For Diabetes Care Products 64

St. Jude Medical Enters Into Distribution Agreement With Spinal Modulation For Axium Neurostimulator System 65

Epizyme Enters Into Co-Development Agreement With Abbott Labs 66

BioGenex Labs Enters Into Co-Marketing Agreement With Abbott Molecular 67

Cellavision Enters Into Distribution Agreement With Abbott 68

Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 69

BioView Enters Into Agreement With Abbott To Develop Automated Cancer Screening System 70

Abaxis Enters Into Distribution Agreement With Abbott Point of Care For Piccolo Blood Chemistry System 71

Alere Enters Into Co-Development Agreement With AT&T 72

Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 73

Abbott Vascular Enters Into Co-Marketing Agreement With St. Jude Medical 74

Abbott Enters Into Co-Development Agreement With Genetics Lab For Molecular Assay Development 75

Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis 76

Novartis Enters into Licensing Agreement with Abbott Vascular for Everolimus 77

Abbott Labs Plans to Raise USD3 Billion in Public Offering of Shares 78

Abbott Labs Raises USD1.33 Billion in Public Offering of 1.5% Bonds Due 2026 79

Abbott Labs Raises USD1.33 Billion in Public Offering of 0.875% Bonds Due 2023 80

Abbott Labs Raises USD1.33 Billion in Public Offering of Bonds Due 2020 81

Abbott Labs Raises USD3 Billion in Public Offering of 3.75% Notes due 2026 82

Abbott Labs Raises USD1.5 Billion in Public Offering of 3.4% Notes Due 2023 84

Abbott Labs Raises USD1.65 Billion in Public Offering of 4.75% Notes due 2036 86

Abbott Labs Raises USD2.85 Billion in Public Offering of 2.9% Notes due 2021 88

Abbott Labs Raises USD2.85 Billion in Public Offering of 2.35% Notes due 2019 90

Abbott Labs Raises USD3.25 Billion in Public Offering of 4.9% Notes due 2046 92

Alere Raises USD425 Million in Private Placement of 6.37% Notes Due 2023 94

Abbott Labs Raises USD750 Million in Public Offering of 2.55% Notes Due 2022 95

Abbott Labs Raises USD1 Billion in Public Offering of 2.55% Notes Due 2025 96

Abbott Labs Raises USD2.5 Billion in Public Offering of 2% Notes Due 2020 97

Alere Completes Private Placement Of Notes Due 2020 For US5 Million 98

St. Jude Medical Completes Public Offering Of Notes Due 2043 For US0 Million 99

St. Jude Medical Completes Public Offering Of Notes Due 2023 For US0 Million 101

Alere Completes Private Placement Of Notes Due 2018 For US0 Million 103

Abbott Completes Private Placement Of Notes Due 2018 For US Billion 104

Abbott Completes Private Placement Of Notes Due 2022 For US.1 Billion 105

Abbott Completes Private Placement Of Notes Due 2042 For US.6 Billion 106

Abbott Completes Private Placement Of Notes Due 2015 For US.5 Billion 107

Abbott Completes Private Placement Of Notes Due 2017 For US Billion 108

Abbott Completes Private Placement Of Notes Due 2015 For US0 Million 109

Quidel Acquires Triage and BNP Business from Alere 110

Terumo Acquires Portion of Vascular Closure Portfolio and Other Assets from St. Jude Medical and Abbott Labs for USD1.12 Billion 112

QIAGEN Acquires Circulating Tumor Cell Technology from AdnaGen 114

Coppersmith Capital Management Reportedly Wants Alere To Explore Sale Of Its Drug Testing And Toxicology Businesses For Up To US Billion 115

Vascular Solutions Acquires Venture Catheter From St. Jude Medical For US Million 116

Siemens Healthineers Acquires Epocal from Alere 117

Abbott Labs Acquires Alere 118

Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 120

Abbott Labs Acquires St. Jude Medical for up to USD23.6 Billion 121

Abbott Labs Acquires Kalila Medical 123

St. Jude Medical Acquires Thoratec for USD3.3 Billion 124

Abbott Labs Acquires Remaining Stake in Tendyne for USD250 Million 126

Abbott Labs Enters into Option Agreement to Acquire Cephea Valve Technologies 127

Abbott Labs Acquires Omnilab 128

Alere Acquires US Diagnostics USD60 Million 129

St. Jude Medical Acquires Spinal Modulation 130

Abbott Labs Acquires Topera 131

Abbott Labs Receives Right to Acquire Advanced Cardiac Therapeutics 132

Ron Zwanziger Plans to Acquire Alere for USD3.82 Billion 133

Jude Medical Completes Acquisition of NeuroTherm for USD200 Million 134

St. Jude Medical Completes Acquisition of Remaining 81% Stake in CardioMEMS for USD450 Million 135

St. Jude Medical Completes Acquisition Of Nanostim For US3.5 Million 137

Abbott Laboratories Completes Acquisition Of IDev Technologies 139

Abbott Labs Completes Acquisition Of OptiMedica For Up To USD410 Million 141

St. Jude Medical Acquires Endosense, Developer Of Cardiovascular Devices 143

Alere Completes Acquisition Of Epocal For Up To US1 Million 145

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 147

Alere Acquires eScreen for USD296 Million 149

Arriva Medical Acquires AmMed Direct For US Million 151

STARLIMS Technologies Acquires Distribution Partners 152

Arriva Medical Acquires Direct Diabetic Source 153

Abbott Laboratories, Key Competitors 154

Abbott Laboratories, Key Employees 155

Abbott Laboratories, Other Locations 157

Abbott Laboratories, Subsidiaries 157

List Of Figures, Charts and Diagrams
in Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

List of Figures

Abbott Laboratories, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Abbott Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Abbott Laboratories, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Abbott Laboratories, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Abbott Laboratories, Medical Equipment, Deals By Year, 2012 to YTD 2018 10

Abbott Laboratories, Medical Equipment, Deals by Type, 2012 to YTD 2018 11

Abbott Laboratories, Medical Equipment, Deals By Region, 2012 to YTD 2018 12

Abbott Laboratories, Medical Equipment, Deals by Market, 2012 to YTD 2018 13

Additional Details

Publisher

Global Data

Publisher Information

Reference

225175 | GDME1255D

Number of Pages

211

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Abbott Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update
SummaryAbbott Vascular Inc. (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Labor...
30 Mar 2016 by Global Data USD $750 More Info
Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAbbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures...
09 Mar 2016 by Global Data USD $250 More Info
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth st...
07 Mar 2016 by Global Data USD $125 More Info
Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures...
24 Feb 2016 by Global Data USD $250 More Info
Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Diabetes Care, Inc. (ADC), formerly TheraSense, Inc. a subsidiary of Abbott Laboratori...
23 Feb 2016 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott Molecular), a subsidiary of Abbott Laboratories is a medical di...
23 Feb 2016 by Global Data USD $250 More Info
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into t...
11 Jan 2016 by Global Data USD $125 More Info
Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Diabetes Care, Inc. (ADC)formerly known as TheraSense, Inc., discovers, develops, manu...
15 Oct 2015 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott) is a medical diagnostic company. The company provides molecula...
15 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data